The use of combination therapy in the treatment of non-alcoholic steatohepatitis

The use of combination therapy in the treatment of non-alcoholic steatohepatitis

Information letter of the Ukrainian Center for Scientific Medical Information and Patent licensing activity of Ukraine Ministry of Health of innovation in the health care system, "Application of combination therapy in the treatment of nonalcoholic steatohepatitis".

In this paper we describe the use of combining hepatoprotective Forsliv in patients with nonalcoholic steatohepatitis. Application Forsliva for months in these patients leads to improved clinical status due to the decrease of asthenic and dyspeptic syndromes, as well as to the probable reduction of cytolytic and cholestatic syndromes.

Full text: PDF